Click to Swap Windows

Objectives
Floyd R. Sallee, M.D., Ph.D.
ADHD: Historical Timeline
ADHD Prevalence
ADHD: Worldwide Prevalence in
Diagnosis of ADHD :
ADHD: Pathophysiology
Brain Image
ADHD
ADHD
ADHD
ADHD
ADHD
ADHD
ADHD
ADHD
ADHD
ADHD
Increased Traffic Violations and Motor Vehicle Accidents in Adolescents and Adults with ADHD
Sexual Behavior: Longitudinal follow-up of cohort of children with ADHD
Continuation of Impairment of ADHD
Comorbidity: A feature of Complicated ADHD
Frequent Complications
ADHD and Conduct disorder
Comorbidity Risk: PSUD in ADHD
ADHD
Pharmacotherapy
Suspected Neurochemical
Short-Acting Versus Once-daily Therapies
Methylphenidate: Effective PK Profiles
Once-daily Stimulants Used to Treat ADHD
Atomoxetine: Site of Action
Atomoxetine-related Dopamine Activity in Select Brain Regions
Methylphenidate-related Dopamine Activity in Select Brain Regions
Atomoxetine Effects on Dopamine
ADHD Rating Scale Improvements
ADHD Rating Scale Improvements
ADHD Rating Scale Improvements
A Fixed Dose Atomoxetine vs Placebo in Children and Adolescents
Atomoxetine - Relationship Between Dose And Symptom Change During Treatment
Study III - Child Health Questionnaire (CHQ) Subscale Scores
Study III - Child Health Questionnaire (CHQ) Subscale Scores
Study III - Child Health Questionnaire (CHQ) Subscale Scores
Community Assessment Trial
Community Assessment Trial
PedsQL
Community Assessment Trial
Community Assessment Trial
PedsQL Total Score:
AAP Recommendations for ADHD Therapy
Psychiatry Division-Consultation Care Clinic-for selected PC groups
Psychiatry Division-Consultation Care Clinic-for selected PC groups
ADHD

F. Randy Sallee, M.D., Ph.D.

Attention Deficit - Hyperactivity Disorder